Lagos allocates 5% of health budget to immunisation,

Lagos State is reinforcing its commitment to vaccine delivery infrastructure, with officials confirming that approximately 5% of the state's annual health budget—either directly or through cross-sector programmes—supports immunisation initiatives. The disclosure came during World Immunisation Week, when the Lagos State Primary Health Care Board's Permanent Secretary, Ibrahim Mustafa, outlined the scale of public health investment required to sustain routine immunisation coverage at 66%, a benchmark that reflects both progress and persistent gaps in Africa's most populous state.

## What does a 66% immunisation coverage rate mean for public health?

A routine coverage rate of 66% places Lagos above several African peers but below World Health Organization (WHO) targets of 90%+ for herd immunity. This gap exposes roughly one-third of the state's under-five population to vaccine-preventable diseases, creating pockets of vulnerability that can spark outbreaks. The investment in immunisation infrastructure—cold chains, trained health workers, community outreach—underpins this 66%, though it also signals that the current 5% allocation may not yet be sufficient to close the remaining coverage deficit, particularly in underserved peri-urban and rural zones.

## Why is Lagos's immunisation spend a bellwether for Nigeria's health economy?

Lagos State, home to over 15 million people and Nigeria's commercial hub, functions as a proxy for the nation's healthcare ambitions. Its budgetary decisions ripple across private sector confidence, foreign direct investment in pharmaceuticals, and donor confidence in Nigeria's ability to meet Sustainable Development Goal 3 (health and well-being). A 5% health budget allocation to immunisation—while appearing modest—represents a deliberate policy choice in a context where education, security, and infrastructure compete fiercely for state resources. If Lagos sustains and scales this commitment, it signals to multinational vaccine manufacturers and health-tech firms that Nigeria presents a viable, growing market.

## How does vaccine coverage translate to economic returns?

The economics are compelling. Every dollar spent on routine childhood immunisation yields an estimated $16 return through avoided disease treatment, lost-productivity recovery, and reduced maternal/neonatal complications. Lagos's 66% coverage baseline, if raised to 85–90%, could prevent tens of thousands of preventable deaths annually and unlock healthcare cost savings that free up state budget for other pressing needs. This efficiency gain also attracts impact investors and global health funders—Gates Foundation, Gavi, UNICEF—who prioritise states demonstrating fiscal discipline and epidemiological rigour.

## What barriers remain in scaling immunisation coverage?

Despite budget allocations, Lagos faces structural challenges: vaccine hesitancy in some communities, fragmented data systems that obscure true coverage gaps, limited last-mile logistics to rural settlements, and competing health priorities (maternal health, malaria, tuberculosis). The 24-percentage-point gap between current coverage (66%) and WHO targets signals that incremental spending increases alone may not suffice; targeted campaigns in low-coverage local government areas (LGAs) and private-sector partnerships will be essential to accelerate progress.

Lagos's immunisation investment, while symbolic of Nigeria's health sector maturation, remains a work in progress. Investors should monitor whether the state increases this allocation in the 2025–2026 budget cycle and how effectively it translates budget to on-ground coverage gains.

---

#